Michael R. Bishop to Lymphoma, B-Cell
This is a "connection" page, showing publications Michael R. Bishop has written about Lymphoma, B-Cell.
Connection Strength
0.281
-
Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic. Biol Blood Marrow Transplant. 2020 07; 26(7):1239-1246.
Score: 0.172
-
Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation. Blood. 2013 Dec 12; 122(25):4129-39.
Score: 0.109